Nextgen Biomed Ltd (TLV: NXGN)
Israel
· Delayed Price · Currency is ILS · Price in ILA64.60
-1.40 (-2.12%)
Dec 16, 2024, 5:24 PM IDT
Nextgen Biomed Balance Sheet
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 0.19 | 0.05 | 5.24 | 11.96 | 5.67 | 1.88 | Upgrade
|
| Short-Term Investments | 0.02 | 0.02 | - | - | 0.02 | 0.02 | Upgrade
|
| Cash & Short-Term Investments | 0.21 | 0.07 | 5.24 | 11.96 | 5.69 | 1.9 | Upgrade
|
| Cash Growth | -91.04% | -98.76% | -56.19% | 110.08% | 199.63% | -37.62% | Upgrade
|
| Other Receivables | 0.19 | 0.07 | - | 0.15 | 0.16 | 0 | Upgrade
|
| Receivables | 0.19 | 0.07 | - | 0.15 | 0.16 | 0 | Upgrade
|
| Prepaid Expenses | - | 0.01 | 0.01 | 0.16 | 0.05 | 0.03 | Upgrade
|
| Restricted Cash | 0.03 | 0.08 | - | - | - | - | Upgrade
|
| Total Current Assets | 0.43 | 0.23 | 5.25 | 12.27 | 5.9 | 1.93 | Upgrade
|
| Property, Plant & Equipment | 0.36 | 0.03 | - | 0.01 | 0.01 | - | Upgrade
|
| Other Intangible Assets | - | - | 1.55 | 7.29 | - | - | Upgrade
|
| Other Long-Term Assets | 0.03 | - | - | - | 0.5 | - | Upgrade
|
| Total Assets | 0.82 | 0.26 | 14.89 | 23.63 | 8.32 | 1.93 | Upgrade
|
| Accounts Payable | 0.16 | 0.15 | 0.17 | 0.14 | 0.07 | 0.08 | Upgrade
|
| Accrued Expenses | - | 1.02 | 1.09 | 0.73 | 0.63 | 0.68 | Upgrade
|
| Other Current Liabilities | 2.48 | 0.07 | - | - | 0.75 | - | Upgrade
|
| Total Current Liabilities | 2.72 | 1.24 | 1.26 | 0.87 | 1.45 | 0.76 | Upgrade
|
| Other Long-Term Liabilities | - | - | 1.38 | 2.14 | - | - | Upgrade
|
| Total Liabilities | 2.88 | 1.24 | 2.64 | 3.01 | 1.45 | 0.76 | Upgrade
|
| Additional Paid-In Capital | 64.82 | 64.4 | 63.43 | 57.96 | 38.2 | 34.66 | Upgrade
|
| Retained Earnings | -67.76 | -66.05 | -51.86 | -43.29 | -40.74 | -39.44 | Upgrade
|
| Treasury Stock | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Comprehensive Income & Other | 1.01 | 0.8 | 0.8 | 6.07 | 9.52 | 6.07 | Upgrade
|
| Total Common Equity | -1.94 | -0.86 | 12.36 | 20.72 | 6.97 | 1.27 | Upgrade
|
| Minority Interest | -0.12 | -0.12 | -0.11 | -0.1 | -0.1 | -0.1 | Upgrade
|
| Shareholders' Equity | -2.06 | -0.98 | 12.25 | 20.62 | 6.87 | 1.17 | Upgrade
|
| Total Liabilities & Equity | 0.82 | 0.26 | 14.89 | 23.63 | 8.32 | 1.93 | Upgrade
|
| Total Debt | 0.25 | - | - | - | - | - | Upgrade
|
| Net Cash (Debt) | -0.04 | 0.07 | 5.24 | 11.96 | 5.69 | 1.9 | Upgrade
|
| Net Cash Growth | - | -98.76% | -56.19% | 110.08% | 199.63% | -37.62% | Upgrade
|
| Net Cash Per Share | -0.01 | 0.01 | 0.73 | 1.80 | 1.05 | 0.39 | Upgrade
|
| Filing Date Shares Outstanding | 7.64 | 7.29 | 7.22 | 7.22 | 6.34 | 4.83 | Upgrade
|
| Total Common Shares Outstanding | 7.64 | 7.29 | 7.22 | 7.22 | 5.53 | 4.83 | Upgrade
|
| Working Capital | -2.29 | -1.01 | 3.99 | 11.4 | 4.45 | 1.17 | Upgrade
|
| Book Value Per Share | -0.25 | -0.12 | 1.71 | 2.87 | 1.26 | 0.26 | Upgrade
|
| Tangible Book Value | -1.94 | -0.86 | 10.81 | 13.43 | 6.97 | 1.27 | Upgrade
|
| Tangible Book Value Per Share | -0.25 | -0.12 | 1.50 | 1.86 | 1.26 | 0.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.